WUXI BIO (02269) issues a total of 25,575,000 restricted shares.
WuXi Biologics (02269) announced that as of March 25, 2026, it has approved the issuance of a total of 25.575 million restricted shares under the restricted share incentive plan, but it will only be effective after being accepted by the recipients according to the restricted share incentive plan.
Wuxi Bio (02269) announced that on March 25, 2026, it has approved the issuance of a total of 25,575,000 restricted shares under the restricted stock incentive plan. However, the restricted shares can only become effective upon acceptance by the grantees under the restricted stock incentive plan.
Related Articles
ZJLD (06979) nominated Tang Xiangyang as an executive director.
BAIC MOTOR (01958): Terminate A-share listing counseling.
YH ENT (02306) recommends adopting the 2026 stock incentive plan.
ZJLD (06979) nominated Tang Xiangyang as an executive director.
BAIC MOTOR (01958): Terminate A-share listing counseling.
YH ENT (02306) recommends adopting the 2026 stock incentive plan.
